Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Keita Masuzawa, M.D., Ph.D.

Concepts (119)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Keita Masuzawa's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Keita Masuzawa has written about over time.
Foramen Ovale, Patent, 1 publications between 2016 and 2016, average publication date April 2016. Acrylamides, 4 publications between 2017 and 2020, average publication date November 2018. Protein Kinase Inhibitors, 4 publications between 2017 and 2020, average publication date November 2018. Drug Resistance, Neoplasm, 5 publications between 2017 and 2020, average publication date May 2019. Carcinoma, Non-Small-Cell Lung, 9 publications between 2017 and 2020, average publication date June 2019. Aniline Compounds, 4 publications between 2018 and 2020, average publication date September 2019. Lung Neoplasms, 13 publications between 2017 and 2022, average publication date February 2020. Lung Diseases, Interstitial, 2 publications between 2018 and 2022, average publication date July 2020. Receptors, Antigen, T-Cell, gamma-delta, 1 publications between 2020 and 2020, average publication date August 2020. Fibroblast Growth Factor 9, 1 publications between 2021 and 2021, average publication date June 2021. GTPase-Activating Proteins, 1 publications between 2022 and 2022, average publication date August 2022. Guanine Nucleotide Exchange Factors, 1 publications between 2022 and 2022, average publication date August 2022.

To see the data from this visualization as text, click here.
Masuzawa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (119)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.